温馨提示：建议您使用Chrome80、火狐74+、IE9+浏览器 ，当您的浏览器版本过低，可能会影响部分功能正常使用。

主办：天津药物研究院 中国药学会

微信公众号

网站二维码

2025年6月12日 22:57 星期四
首页 > 过刊浏览>2023年第54卷第19期 >2023,54(19):6482-6496. DOI:10.7501/j.issn.0253-2670.2023.19.029
上一篇 | 下一篇

含蒽醌、二苯乙烯苷类中药效-毒转换物质基础及作用机制研究进展

Research progress on substance basis and mechanism of traditional Chinese medicines containing anthraquinone and stilbene glycosides in effect-toxicity conversion

发布日期：2023-09-25
  • 摘要
  • 访问统计
  • PDF预览
  • 参考文献
  • 相似文献
  • 引证文献
    [关键词]
    [摘要]
    有毒中药效-毒转换机制的研究一直是中药合理应用的难点，以蒽醌类、二苯乙烯苷类成分及含有该类成分的中药为研究对象，梳理了这2类效-毒同源物质及其体内代谢规律与产物，分析了效-毒同源物质原型及其代谢产物的构-效与构-毒关系，整合并总结了含蒽醌、二苯乙烯苷类有毒中药的药效与毒性作用机制及毒-效转换关系与规律。为进一步阐释中药效-毒转换机制的研究，基于蛋白组学技术、药物靶点及药物作用机制研究方法，提出了以蒽醌类、二苯乙烯苷类成分为例的中药效-毒转换靶点与机制研究的策略与展望，为中药效-毒转换机制与转换规律的探究提供思路与方法借鉴。
    [Key word]
    [Abstract]
    The study of the efficacy-toxicity conversion mechanism of toxic traditional Chinese medicine (TCM) has always been a difficult point in the rational application of Chinese herbal medicine. In this paper, we have taken the anthraquinones, stilbene glycosides and TCM containing these components as the research objects, sorted out these two types of efficacy-toxicity homologous substances and their metabolism patterns and products in vivo, analyzed the efficacy-toxicity of prototypes of these homologous substances and structure-activity and structure-toxicity relationships of their metabolites, and integrated and summarized the mechanism of efficacy and toxicity, as well as the relationships and patterns of efficacy-toxicity conversion for toxic TCM containing anthraquinone and stilbene glycosides. To further elucidate the mechanism of the efficacy-toxicity conversion of TCM, we proposed strategies and prospects for the study of the targets and mechanism of efficacy-toxicity conversion of Chinese medicines based on proteomics technology, drug targets and drug mechanism of action by taking anthraquinones and stilbene glycosides as examples, in order to provide ideas and methodological reference for the investigation of the rules of efficacy-toxicity conversion of TCM.
    [中图分类号]
    R285
    [基金项目]
    国家自然科学基金资助项目（82174090）；江苏省高校“青蓝工程”中青年学术带头人；江苏省高校333工程第三层次培养对象
    [1] Navarro V J, Khan I, Björnsson E, et al. Liver injury from herbal and dietary supplements[J]. Hepatology, 2017, 65(1):363-373.
    [2] Shen T, Liu Y X, Shang J, et al. Incidence and etiology of drug-induced liver injury in mainland China[J]. Gastroenterology, 2019, 156(8):2230-2241.
    [3] Lee W J, Kim H W, Lee H Y, et al. Systematic review on herb-induced liver injury in Korea[J]. Food Chem Toxicol, 2015, 84:47-54.
    [4] Medina-Caliz I, Garcia-Cortes M, Gonzalez-Jimenez A, et al. Herbal and dietary supplement-induced liver injuries in the Spanish DILI registry[J]. Clin Gastroenterol Hepatol, 2018, 16(9):1495-1502.
    [5] Aiso M, Takikawa H, Tsuji K, et al. Analysis of 307 cases with drug-induced liver injury between 2010 and 2018 in Japan[J]. Hepatol Res, 2019, 49(1):105-110.
    [6] 汪祺, 王亚丹, 文海若, 等. 基于UGT1A1酶抑制探讨何首乌中顺(反)式二苯乙烯苷体外肝微粒体中潜在毒性作用[J]. 中国现代中药, 2019, 21(3):291-295.
    [7] 佚名. 英国MHRA警告何首乌的肝损害不良反应[J]. 中国药物警戒, 2006, 3(5):313-314.
    [8] CFDA. 食品药品监管总局办公厅关于修订养血生发胶囊等6个含何首乌中药口服制剂说明书的通知[EB/OL].[2013-10-23]. http://www.sfda.gov.cn/WS01/CL1706/93676.html.
    [9] CFDA. 食品药品监管总局办公厅关于加强含何首乌保健食品监管有关规定的通知[EB/OL].[2017-03-22] http://www.sfda.gov.cn/WS01/CL0847/102806.html.
    [10] CFDA. 药品不良反应信息通报(第61期)关注口服何首乌机器成方制剂引起的肝损伤风险[EB/OL].[2014-07-16]. http://www.sfda.gov.cn/WS01/CL1989/102903.html.
    [11] CFDA. 国家食品药品监管总局提示关注口服何首乌肝损伤风险[EB/OL].[2014-07-16]. http://www.sda.gov.cn/WS01/CL0051/102902.html.
    [12] Xue X Y, Quan Y Y, Gong L H, et al. A review of the processed Polygonum multiflorum (Thunb.) for hepatoprotection:Clinical use, pharmacology and toxicology[J]. J Ethnopharmacol, 2020, 261:113121.
    [13] Quan N V, Xuan T D, Teschke R. Potential hepatotoxins found in herbal medicinal products:A systematic review[J]. Int J Mol Sci, 2020, 21(14):5011.
    [14] He S B, Zhang C Y, Zhou P, et al. Herb-induced liver injury:Phylogenetic relationship, structure-toxicity relationship, and herb-ingredient network analysis[J]. Int J Mol Sci, 2019, 20(15):3633.
    [15] Shen P, Han L, Chen G, et al. Emodin attenuates acetaminophen-induced hepatotoxicity via the cGAS-Sting pathway[J]. Inflammation, 2022, 45(1):74-87.
    [16] Dong X, Zeng Y W, Liu Y, et al. Aloe-emodin:A review of its pharmacology, toxicity, and pharmacokinetics[J]. Phytother Res, 2020, 34(2):270-281.
    [17] Lin H J, Chao P D L, Huang S Y, et al. Aloe-emodin suppressed NMDA-induced apoptosis of retinal ganglion cells through regulation of ERK phosphorylation[J]. Phytother Res, 2007, 21(11):1007-1014.
    [18] 王伽伯, 马永刚, 张萍, 等. 炮制对大黄化学成分和肝肾毒性的影响及其典型相关分析[J]. 药学学报, 2009, 44(8):885-890.
    [19] Deng Z Y. Protective effect of rhein against oxidative stress-related endothelial cell injury[J]. Mol Med Report, 2012, 5(5):1261-1266.
    [20] He L N, Yang A H, Cui T Y, et al. Reactive metabolite activation by CYP2C19-mediated rhein hepatotoxicity[J]. Xenobiotica, 2015, 45(4):361-372.
    [21] Kuo C Y, Chiu V, Hsieh P C, et al. Chrysophanol attenuates hepatitis B virus X protein-induced hepatic stellate cell fibrosis by regulating endoplasmic reticulum stress and ferroptosis[J]. J Pharmacol Sci, 2020, 144(3):172-182.
    [22] Sun Y, Xin X, Zhang K H, et al. Cytochrome P450 mediated metabolic activation of chrysophanol[J]. Chem Biol Interact, 2018, 289:57-67.
    [23] Park Y J, Lee K H, Jeon M S, et al. Hepatoprotective potency of chrysophanol 8-O-glucoside from Rheum palmatum L. against hepatic fibrosis via regulation of the STAT3 signaling pathway[J]. Int J Mol Sci, 2020, 21(23):9044.
    [24] Kang L, Si L, Rao J, et al. Polygoni Multiflori Radix derived anthraquinones alter bile acid disposition in sandwich-cultured rat hepatocytes[J]. Toxicol In Vitro. 2017, 40:313-323.
    [25] 张志国, 吕泰省, 姚庆强. 何首乌蒽醌类化学成分研究[J]. 中草药, 2006, 37(9):1311-1313.
    [26] 孙晋苓, 黄晓兰, 吴惠勤, 等. 液相色谱/离子阱质谱法研究何首乌中糖苷类化合物[J]. 天然产物研究与开发, 2009, 21(5):806-812.
    [27] Yang X W, Gu Z M, Ma C M, et al. A new indole derivative isolated from the root of tuber fleeceflower (Polygonum multiflorum)[J]. 中草药, 1998, 29:5-11.
    [28] Yu H S, Wang L L, He Y, et al. Advances in the study of the potential hepatotoxic components and mechanism of Polygonum multiflorum[J]. Evid Based Complementary Altern Med, 2020, 2020:1-12.
    [29] Lin L F, Lin H M, Zhang M, et al. A novel method to analyze hepatotoxic components in Polygonum multiflorum using ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry[J]. J Hazard Mater, 2015, 299:249-259.
    [30] 王浩. 何首乌药材生产技术研究[D]. 广州:广东药科大学, 2021.
    [31] Teka T, Wang L M, Gao J, et al. Polygonum multiflorum:Recent updates on newly isolated compounds, potential hepatotoxic compounds and their mechanisms[J]. J Ethnopharmacol, 2021, 271:113864.
    [32] Zhang Y, Jiang M, Cui B W, et al. P2X7 receptor-targeted regulation by tetrahydroxystilbene glucoside in alcoholic hepatosteatosis:A new strategy towards macrophage-hepatocyte crosstalk[J]. Br J Pharmacol, 2020, 177(12):2793-2811.
    [33] Wang W G, He Y R, Lin P, et al. In vitro effects of active components of Polygonum Multiflorum Radix on enzymes involved in the lipid metabolism[J]. J Ethnopharmacol, 2014, 153(3):763-770.
    [34] Wang Y Y, Yang J, Liu H, et al. Effects of tetrahydroxystilbene glucoside on mouse liver cytochrome P450 enzyme expressions[J]. Xenobiotica, 2015, 45(4):279-285.
    [35] He J B, Chen K, Deng T C, et al. Inhibitory effects of rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activity[J]. Front Pharmacol, 2021, 12:645140.
    [36] Dong X, Fu J, Yin X B, et al. Induction of apoptosis in HepaRG cell line by aloe-emodin through generation of reactive oxygen species and the mitochondrial pathway[J]. Cell Physiol Biochem, 2017, 42(2):685-696.
    [37] 林艳, 肖榕, 尹林子, 等. 基于粗糙集理论构建"谱毒"关系研究何首乌特异质肝毒性物质基础[J]. 中国中药杂志, 2019, 44(3):509-517.
    [38] Yang L, Xing W, Xiao W Z, et al. 2,3,5,4'-tetrahydroxy-stilbene-2-O-beta-D-glucoside induces autophagy-mediated apoptosis in hepatocytes by upregulating miR-122 and inhibiting the PI3K/Akt/mTOR pathway:Implications for its hepatotoxicity[J]. Pharm Biol, 2020, 58(1):806-814.
    [39] Qiu X H, Zhang J, Huang Z H, et al. Profiling of phenolic constituents in Polygonum multiflorum Thunb. by combination of ultra-high-pressure liquid chromatography with linear ion trap-Orbitrap mass spectrometry[J]. J Chromatogr A, 2013, 1292:121-131.
    [40] 陈万生, 刘文庸, 杨根金, 等. 制首乌中1个新的四羟基二苯乙烯苷的结构鉴定及其心血管活性研究[J]. 药学学报, 2000(12):906-908.
    [41] Zheng X Y, Yang S M, Zhang R, et al. Emodin-induced autophagy against cell apoptosis through the PI3K/Akt/mTOR pathway in human hepatocytes[J]. Drug Des Dev Ther, 2019, 13:3171-3180.
    [42] 梁幼玲, 史旭华, 白俊其, 等. 采用UHPLC-MS和质量亏损过滤技术分析二苯乙烯苷在大鼠体内的代谢产物和代谢途径[J]. 中国药房, 2021, 32(6):675-681.
    [43] Wu W J, Yan R, Yao M C, et al. Pharmacokinetics of anthraquinones in rat plasma after oral administration of a rhubarb extract[J]. Biomed Chromatogr, 2014, 28(4):564-572.
    [44] Shia C S, Juang S H, Tsai S Y, et al. Metabolism and pharmacokinetics of anthraquinones in Rheum palmatum in rats and ex vivo antioxidant activity[J]. Planta Med, 2009, 75(13):1386-1392.
    [45] Liu W, Tang L, Ye L, et al. Species and gender differences affect the metabolism of emodin via glucuronidation[J]. AAPS J, 2010, 12(3):424-436.
    [46] Shia C S, Hou Y C, Tsai S Y, et al. Differences in pharmacokinetics and ex vivo antioxidant activity following intravenous and oral administrations of emodin to rats[J]. J Pharm Sci, 2010, 99(4):2185-2195.
    [47] Bachmann M, Schlatter C. Metabolism of[14C] emodin in the rat[J]. Xenobiotica, 1981, 11(3):217-225.
    [48] Song R, Xu F G, Zhang Z J, et al. Structural elucidation of in vitro metabolites of emodin by liquid chromatography-tandem mass spectrometry[J]. Biomed Chromatogr, 2008, 22(11):1230-1236.
    [49] Huang Z H, Xu Y, Wang Q, et al. Metabolism and mutual biotransformations of anthraquinones and anthrones in rhubarb by human intestinal flora using UPLC-Q-TOF/MS[J]. J Chromatogr B, 2019, 1104:59-66.
    [50] Song R, Xu L, Xu F G, et al. In vivo metabolism study of rhubarb decoction in rat using high-performance liquid chromatography with UV photodiode-array and mass-spectrometric detection:A strategy for systematic analysis of metabolites from traditional Chinese medicines in biological samples[J]. J Chromatogr A, 2010, 1217(45):7144-7152.
    [51] Yu C P, Shia C S, Lin H J, et al. Analysis of the pharmacokinetics and metabolism of aloe-emodin following intravenous and oral administrations in rats[J]. Biomed Chromatogr, 2016, 30(10):1641-1647.
    [52] 汪祺, 王亚丹, 杨建波, 等. 基于II相代谢酶探讨大黄中大黄酸潜在肝毒性[J]. 中国中药杂志, 2020, 45(2):412-417.
    [53] 董萍萍, 王少平, 王喻淇, 等. UHPLC-Q-Exactive-Orbitrap HR-MS分析大黄素甲醚在大鼠体内的代谢产物[J]. 中成药, 2021, 43(12):3524-3531.
    [54] Song R, Xu L, Xu F G, et al. Metabolic analysis of rhubarb extract by rat intestinal bacteria using liquid chromatography-tandem mass spectrometry[J]. Biomed Chromatogr, 2011, 25(3):417-426.
    [55] 张桔平. 何首乌大鼠体内代谢产物分析及鉴定[D]. 广州:广州中医药大学, 2018.
    [56] Friedman M, Xu A, Lee R, et al. The inhibitory activity of anthraquinones against pathogenic Protozoa, bacteria, and fungi and the relationship to structure[J]. Molecules, 2020, 25(13):3101.
    [57] 宗金锐, 巢志茂, 刘振丽, 等. 大黄中蒽醌衍生物的构效关系[J]. 中国中药杂志, 2008, 33(20):2424-2427.
    [58] 胡樱凡. 大黄蒽醌类化合物抑制LPS诱导巨噬细胞炎症反应的分子机制及其构效关系的研究[D]. 成都:成都中医药大学, 2019.
    [59] Qin B Y, Xu Y, Chen J M, et al. Chemical reactivity of emodin and its oxidative metabolites to thiols[J]. Chem Res Toxicol, 2016, 29(12):2114-2124.
    [60] Cui Y T, Liu B, Xie J, et al. The effect of emodin on cytotoxicity, apoptosis and antioxidant capacity in the hepatic cells of grass carp (Ctenopharyngodon idellus)[J]. Fish Shellfish Immunol, 2014, 38(1):74-79.
    [61] Wang X, Xin X, Sun Y, et al. Chemical reactivity of aloe-emodin and its hydroxylation metabolites to thiols[J]. Chem Res Toxicol, 2019, 32(2):234-244.
    [62] 林佩, 陆建美, 张光远, 等. 何首乌活性成分在肝L-02细胞中吸收及代谢产物的LC-MS/MS定性分析[J]. 中国药学杂志, 2015, 50(12):1048-1053.
    [63] Wang J, Zhao H, Kong W, et al. Microcalorimetric assay on the antimicrobial property of five hydroxyanthraquinone derivatives in rhubarb (Rheum palmatum L.) to Bifidobacterium adolescentis[J]. Phytomedicine, 2010, 17(8/9):684-689.
    [64] 马红玉. 蒽醌类成分的体内外检测研究[D]. 贵阳:贵州大学, 2015.
    [65] Wang D P, Wang X H, Yu X J, et al. Pharmacokinetics of anthraquinones from medicinal plants[J]. Front Pharmacol, 2021, 12:638993.
    [66] 郭延丽, 唐瑜, 刘巧, 等. 何首乌及其主要成分肝毒性机制的研究进展[J]. 药物评价研究, 2021, 44(10):2252-2261.
    [67] Zhang L, Liu X Y, Tu C, et al. Components synergy between stilbenes and emodin derivatives contributes to hepatotoxicity induced by Polygonum multiflorum[J]. Xenobiotica, 2020, 50(5):515-525.
    [68] 胡存华, 叶少剑, 赵立波, 等. 五种二苯乙烯类化合物对一氧化氮介导的血管舒张反应的影响及构效关系[J]. 中国医院药学杂志, 2006, 26(7):826-829.
    [69] 吕丽爽, Chi-Tang Ho, 汤坚. 二苯乙烯苷和白藜芦醇抗氧化构效关系研究[J]. 食品与机械, 2009, 25(5):57-58.
    [70] 洪雪琪. 何首乌活性成分二苯乙烯苷对胃癌细胞的生物学行为影响及肝毒性的研究[D]. 南宁:广西医科大学, 2020.
    [71] Shen C, Sun F L, Zhang R Y, et al. Tetrahydroxystilbene glucoside ameliorates memory and movement functions, protects synapses and inhibits α-synuclein aggregation in hippocampus and striatum in aged mice[J]. Restor Neurol Neurosci, 2015, 33(4):531-541.
    [72] Mu Y, Xu Z H, Zhou X X, et al. 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside attenuates ischemia/reperfusion-induced brain injury in rats by promoting angiogenesis[J]. Planta Med, 2016, 83(8):676-683.
    [73] 王春英, 袁志芳, 王巧, 等. HPLC法同时测定大鼠胆汁中二苯乙烯苷及其代谢物的浓度[J]. 药物分析杂志, 2009, 29(1):53-57.
    [74] Li D, Yang M B, Zuo Z. Overview of pharmacokinetics and liver toxicities of Radix Polygoni Multiflori[J]. Toxins, 2020, 12(11):729.
    [75] Meng Y K, Li C Y, Li R Y, et al. Cis-stilbene glucoside in Polygonum multiflorum induces immunological idiosyncratic hepatotoxicity in LPS-treated rats by suppressing PPAR-γ[J]. Acta Pharmacol Sin, 2017, 38(10):1340-1352.
    [76] Song R, Lin H, Zhang Z J, et al. Profiling the metabolic differences of anthraquinone derivatives using liquid chromatography/tandem mass spectrometry with data-dependent acquisition[J]. Rapid Commun Mass Spectrom, 2009, 23(4):537-547.
    [77] 林艳, 李亚梅, 吴萍, 等. 何首乌肝毒性的物质基础、毒性机制与防控策略[J]. 世界科学技术-中医药现代化, 2019, 21(9):1862-1868.
    [78] 徐风, 杨东辉, 尚明英, 等. 中药药效物质的"显效形式""叠加作用"和"毒性分散效应":由中药体内代谢研究引发的思考[J]. 世界科学技术-中医药现代化, 2014, 16(4):688-703.
    [79] Liu H, Gu L B, Tu Y, et al. Emodin ameliorates cisplatin-induced apoptosis of rat renal tubular cells in vitro by activating autophagy[J]. Acta Pharmacol Sin, 2016, 37(2):235-245.
    [80] Dai S S, Ye B Z, Chen L W, et al. Emodin alleviates LPS-induced myocardial injury through inhibition of NLRP3 inflammasome activation[J]. Phytother Res, 2021, 35(9):5203-5213.
    [81] Evans L W, Bender A, Burnett L, et al. Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy[J]. J Nutr Biochem, 2020, 79:108339.
    [82] Lee H Z. Protein kinase C involvement in aloe-emodin-and emodin-induced apoptosis in lung carcinoma cell[J]. Br J Pharmacol, 2001, 134(5):1093-1103.
    [83] Zhuang T X, Gu X Y, Zhou N, et al. Hepatoprotection and hepatotoxicity of Chinese herb rhubarb (Dahuang):How to properly control the "General (Jiang Jun)" in Chinese medical herb[J]. Biomed Pharmacother, 2020, 127:110224.
    [84] Lu C C, Yang J S, Huang A C, et al. Chrysophanol induces necrosis through the production of ROS and alteration of ATP levels in J5 human liver cancer cells[J]. Mol Nutr Food Res, 2010, 54(7):967-976.
    [85] Zhang S B, Wu Z Q, Shi L, et al. 2,3,5,4'-Tetrahydroxy-stilbene-2-O-β-D-glucoside ameliorates NAFLD via attenuating hepatic steatosis through inhibiting mitochondrial dysfunction dependent on SIRT5[J]. Phytomedicine, 2022, 99:153994.
    [86] 刘美辰, 李芸霞, 全云云, 等. 何首乌二苯乙烯苷对肝脏的作用及机制研究进展[J]. 辽宁中医杂志, 2018, 45(6):1318-1321.
    [87] Kwon K S, Lee J H, So K S, et al. Aurantio-obtusin, an anthraquinone from cassiae semen, ameliorates lung inflammatory responses[J]. Phytother Res, 2018, 32(8):1537-1545.
    [88] Chin Y T, Hsieh M T, Lin C Y, et al. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-glucoside isolated from Polygoni Multiflori ameliorates the development of periodontitis[J]. Mediators Inflamm, 2016, 2016:6953459.
    [89] Lee B H, Huang Y Y, Duh P D, et al. Hepatoprotection of emodin and Polygonum multiflorum against CCl4-induced liver injury[J]. Pharm Biol, 2012, 50(3):351-359.
    [90] Su S Y, Wu J S, Gao Y, et al. The pharmacological properties of chrysophanol, the recent advances[J]. Biomed Pharmacother, 2020, 125:110002.
    [91] Wu J J, Hu W F, Gong Y, et al. Current pharmacological developments in 2,3,4',5-tetrahydroxystilbene 2-O-β-D-glucoside (TSG)[J]. Eur J Pharmacol, 2017, 811:21-29.
    [92] Jiang L L, Zhao D S, Fan Y X, et al. Detection of emodin derived glutathione adduct in normal rats administered with large dosage of Polygoni Multiflori Radix[J]. Front Pharmacol, 2017, 8:446.
    [93] Qiu L Z, Yue L X, Ni Y H, et al. Emodin-induced oxidative inhibition of mitochondrial function assists BiP/IRE1α/Chop signaling-mediated ER-related apoptosis[J]. Oxid Med Cell Longev, 2021, 2021:1-13.
    [94] He L Z, Yin P, Meng Y K, et al. Immunological synergistic mechanisms of trans-/cis-stilbene glycosides in Heshouwu-related idiosyncratic liver injury[J]. Sci Bull, 2017, 62(11):748-751.
    [95] Zhang Y, Ding T, Diao T T, et al. Effects of Polygonum multiflorum on the activity of cytochrome P450 isoforms in rats[J]. Pharmazie. 2015, 70(1):47-54.
    [96] Yu Q, Jiang L L, Luo N, et al. Enhanced absorption and inhibited metabolism of emodin by 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucopyranoside:Possible mechanisms for Polygoni Multiflori Radix-induced liver injury[J]. Chin J Nat Med, 2017, 15(6):451-457.
    [97] Liu X Y, Liu Y Q, Cheng M C, et al. Metabolomic responses of human hepatocytes to emodin, aristolochic acid, and triptolide:Chemicals purified from traditional Chinese medicines[J]. J Biochem Mol Toxicol, 2015, 29(11):533-543.
    [98] Perez M J, Briz O. Bile-acid-induced cell injury and protection[J]. World J Gastroenterol, 2009, 15(14):1677-1689.
    [99] Li Y X, Gong X H, Liu M C, et al. Investigation of liver injury of Polygonum multiflorum Thunb. in rats by metabolomics and traditional approaches[J]. Front Pharmacol, 2017, 8:791.
    [100] Huang D L, Li C P, Wang J B, et al. Correlational verification of drug-induced liver injury with HLA-B*35:01 allele due to Polygonum multiflorum[J]. Chin J Hepatol, 2021, 29(11):1106-1108.
    [101] Yang W N, Pang L L, Zhou J Y, et al. Single-nucleotide polymorphisms of HLA and Polygonum multiflorum-induced liver injury in the Han Chinese population[J]. World J Gastroenterol, 2020, 26(12):1329-1339.
    [102] Dai L Y, Li Z J, Chen D, et al. Target identification and validation of natural products with label-free methodology:A critical review from 2005 to 2020[J]. Pharmacol Ther, 2020, 216:107690.
    [103] Lin L F, Li H, Lin H M, et al. Application of iTRAQ-based quantitative proteomics approach to identify deregulated proteins associated with liver toxicity induced by Polygonum multiflorum in rats[J]. Cell Physiol Biochem, 2017, 43(5):2102-2116.
    [104] 杨晓伟, 张银环, 段飞鹏, 等. 基于Lable-free蛋白质组学技术研究大黄素致大鼠肝损伤作用机制[J]. 世界中医药, 2019, 14(2):320-325.
    [105] Brioschi M, Gianazza E, Agostoni P, et al. Multiplexed MRM-based proteomics identified multiple biomarkers of disease severity in human heart failure[J]. Int J Mol Sci, 2021, 22(2):838.
    [106] Wei Q, Ling Z Y, Huan T, et al. Chemoproteomic profiling of itaconation by bioorthogonal probes in inflammatory macrophages[J]. J Am Chem Soc, 2020, 142(25):10894-10898.
    [107] Dai J Y, Liang K, Zhao S, et al. Chemoproteomics reveals baicalin activates hepatic CPT1 to ameliorate diet-induced obesity and hepatic steatosis[J]. Proc Natl Acad Sci USA, 2018, 115(26):E5896-E5905.
    [108] Liu Y, Liu X J, Zhang N, et al. Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5[J]. Acta Pharm Sin B, 2020, 10(12):2299-2312.
友情链接中华人民共和国科学技术部
您是第12390277位访问者
中草药 ® 2025 版权所有
技术支持：北京勤云科技发展有限公司
津备案：津ICP备13000267号 互联网药品信息服务资格证书编号：（津）-非经营性-2015-0031
请使用 Firefox、Chrome、IE10、IE11、360极速模式、搜狗极速模式、QQ极速模式等浏览器，其他浏览器不建议使用!